Sarmiento, Rommel .

HRN: 27-35-18  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/27/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/27/2025
08/03/2025
IV
2.25g
Q6h
HAP
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: